Literature DB >> 35387208

Scleroderma associated with renal cell carcinoma: A case report and literature review.

Hiral S Patel1, Vanya Aggarwal1, Rupak Thapa2.   

Abstract

Introduction: Systemic sclerosis (aka scleroderma) is an autoimmune disease with no known definitive etiology, but genetic, infectious, and non-infectious exposures have been associated with its occurrence. Previous studies have shown that systemic sclerosis can be a paraneoplastic phenomenon and may be associated with increased risk of malignancy, most commonly lung, skin, and breast cancers. The association of renal cell carcinoma with systemic sclerosis is rare. Case Description: Here, we present a case of a 75-year-old male patient with a rapidly progressive scleroderma despite the initial treatment with methotrexate and prednisone 5 mg daily. Shortly after the diagnosis of scleroderma, the patient was found to have a renal mass. The patient underwent a right partial nephrectomy revealing papillary renal cell carcinoma. The surgical margin was negative indicating complete removal of the cancer. The patient, later, developed scleroderma renal crisis and progressed to end-stage renal disease despite treatment with captopril, mycophenolate mofetil, plasmapheresis, and intravenous immunoglobulin. Conclusions: The purpose of this case report and literature review is to highlight that diffuse scleroderma can potentially be paraneoplastic from a renal cell carcinoma and to add more data to the literature given there are only a handful of reported cases. Our patient is unique in the sense that he was discovered to have renal cell carcinoma shortly after being diagnosed with scleroderma suggesting a paraneoplastic etiology yet continued to worsen despite full resection of the renal cell carcinoma. This is in contrast to the other reported cases of renal cell carcinoma associated scleroderma where scleroderma worsened around the time of the diagnosis of renal cell carcinoma and improved after nephrectomy. There also are case reports of the patients with renal cell carcinoma associated scleroderma where the patient had scleroderma for several years before the diagnosis of renal cell carcinoma, which raises the question, if scleroderma could also represent a risk factor for developing renal cell carcinoma.
© The Author(s) 2021.

Entities:  

Keywords:  Systemic sclerosis; literature review; paraneoplastic; renal cell carcinoma; scleroderma

Year:  2021        PMID: 35387208      PMCID: PMC8922655          DOI: 10.1177/23971983211013973

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  10 in total

1.  Limited scleroderma with pauci-immune glomerulonephritis in the presence of renal cell carcinoma.

Authors:  Victor Abrich; Sudhir Duvuru; Howard J Swanson
Journal:  Clin Med Res       Date:  2013-05-08

2.  Rapidly progressive systemic sclerosis and acute renal failure associated with a renal cell carcinoma.

Authors:  P A Rutherford; A Davison; T Ringrose; A R Morley; J S Tapson
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

3.  Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.

Authors:  Ami A Shah; Laura K Hummers; Livia Casciola-Rosen; Kala Visvanathan; Antony Rosen; Fredrick M Wigley
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

4.  Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma.

Authors:  D W Puett; H A Fuchs
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

5.  Urologic malignancies and progressive systemic sclerosis.

Authors:  J C Angulo; J I Lopez; N Flores
Journal:  Minerva Urol Nefrol       Date:  1993-03       Impact factor: 3.720

6.  Unusual Occurrence of renal cell carcinoma (RCC) diagnosed in 2 young Hispanic patients with diffuse systemic sclerosis (dSSc).

Authors:  Michelle E Eisenberg; Prashanth R Sunkureddi; Bruce A Baethge; Emilio B Gonzalez; Terry A McNearney
Journal:  J Clin Rheumatol       Date:  2007-12       Impact factor: 3.517

Review 7.  Systemic sclerosis and malignancy: a review of the literature.

Authors:  Marc Wooten
Journal:  South Med J       Date:  2008-01       Impact factor: 0.954

8.  Association between scleroderma, renal cell carcinoma and membranous nephropathy.

Authors:  S Nunez; K N Konstantinov; K S Servilla; M F Hartshorne; W L Williams; L J Gibel; A H Tzamaloukas
Journal:  Clin Nephrol       Date:  2009-01       Impact factor: 0.975

Review 9.  Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.

Authors:  Akira Onishi; Daisuke Sugiyama; Shunichi Kumagai; Akio Morinobu
Journal:  Arthritis Rheum       Date:  2013-07

Review 10.  Systemic Sclerosis and Malignancy: A Review of Current Data.

Authors:  Nabil Zeineddine; Lara El Khoury; Joseph Mosak
Journal:  J Clin Med Res       Date:  2016-07-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.